CLASS II Device recall · Reported 1 Feb 2017 · FDA Enforcement Report

Rigid Laryngostroboscopes The Rigid Laryngostroboscopes recalled

Pentax of America is recalling Rigid Laryngostroboscopes The Rigid Laryngostroboscopes, distributed nationwide in the US. The recall was initiated on 12 Dec 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel #'s 9106 and 9108
Quantity recalled2,056 (1,545 (US) and 511 (OUS))

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1075-2017
FDA event ID
76089
Recalling firm
Pentax of America, Montvale, NJ
Classification
Class II
Status
Terminated
Recall initiated
12 Dec 2016
FDA classified
23 Jan 2017
Reported
1 Feb 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Dec 2016Recall initiated by company
23 Jan 2017Classified by FDA+42 days
1 Feb 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Pentax is initiating a Field Correction to revise the Instructions for Use of the Rigid Laryngostroboscopes Model 9106 and 9108.

Product as listed by the FDA

Rigid Laryngostroboscopes The Rigid Laryngostroboscopes, Models 9106 and 9108 are intended to observe glottic action with the use of a stroboscopic light source. The instrument is inserted per-orally when indications consistent with the need for observation are observed.

Where it was distributed

Worldwide Distribution-US (nationwide) and countries of: Albania, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Ecuador, Egypt, Finland, France, Germany, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Lebanon, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Oman, Philippines, Portugal, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, Trinidad, Turkey, United Arab Emirates, and United Kingdom.

Nationwide

Questions about this recall

Why was it recalled?

Pentax is initiating a Field Correction to revise the Instructions for Use of the Rigid Laryngostroboscopes Model 9106 and 9108.

Which lots are affected?

Model #'s 9106 and 9108

Where was it sold?

Worldwide Distribution-US (nationwide) and countries of: Albania, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Ecuador, Egypt, Finland, France, Germany, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Lebanon, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Oman, Philippines, Portugal, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, Trinidad, Turkey, United Arab Emirates, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pentax of America

All 33

Other Heart & Vascular Devices recalls

All 6,199